Related Experiment Video
Updated: Jul 10, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Selected highlights in the updated treatment of hypertension
Daniel Creegan1, John W McEvoy2
1University Hospital Galway and SAOLTA University Health Care Group, Galway, Ireland; School of Medicine, University of Galway, Ireland.
Insights
This review highlights recent advances in hypertension management, including lower blood pressure targets, renal denervation efficacy, salt intake insights, and the benefits of multidisciplinary care for cardiovascular disease prevention.
Area of Science:
- Cardiology
- Nephrology
- Public Health
Background:
- Hypertension is a primary global risk factor for cardiovascular disease and mortality.
- Despite available treatments, hypertension is frequently underdiagnosed and undertreated.
- Effective management strategies are crucial for reducing cardiovascular events.
Purpose of the Study:
- To provide a concise update on recent developments in hypertension management.
- To highlight key areas for clinical consideration in treating hypertension.
- To inform clinicians about emerging evidence and therapeutic approaches.
Main Methods:
- Review of recent scientific literature and clinical studies.
- Synthesis of evidence on novel treatment targets and interventions.
- Analysis of data related to dietary factors and care models.
Main Results:
- Evidence supports lower systolic blood pressure (BP) treatment targets.
- Renal denervation shows promise in specific hypertensive populations.
- New data informs the ongoing debate on dietary salt intake.
- Multidisciplinary care models demonstrate significant potential for improved outcomes.
Conclusions:
- Lowering systolic BP targets is strongly motivated by new evidence.
- Renal denervation warrants further investigation for hypertension management.
- Dietary salt reduction remains a critical public health consideration.
- Integrating multidisciplinary care can optimize hypertension control and reduce cardiovascular risk.
Abstract:
Hypertension remains the leading international risk factor for cardiovascular disease and premature death but, despite effective treatments, hypertension remains significantly underdiagnosed and undertreated. In the present review paper, we provide a selected update on recent developments of interest in the management of hypertension. We focus on summarizing four topics that we believe are worth highlighting to a clinical audience: (1) the evidence and strong motivation for new lower systolic BP treatment targets; (2) new studies reporting on the efficacy of renal denervation in the management of hypertension; (3) interesting new data to inform the great salt debate; and (4), perhaps most importantly, pioneering new work highlighting the huge potential of multi-disciplinary care in the management of hypertension.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension and Regulation of Blood Pressure
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...

